RG
CELG

Redmile Group’s Celgene Corp CELG Stock Holding History

Redmile Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-562,700
Closed -$55.9M – 88
2019
Q3 		$55.9M Buy
562,700
+5,700
+1% +$542K 1.87% 17
2019
Q2 		$51.5M Buy
557,000
+21,300
+4% +$2.02M 1.46% 21
2019
Q1 		$50.5M Buy
+535,700
New +$46.9M 1.48% 22
2018
Q1 		– Sell
-653,000
Closed -$68.1M – 80
2017
Q4 		$68.1M Buy
+653,000
New +$73.7M 2.96% 10
2016
Q1 		– Sell
-10,055
Closed -$1.2M – 68
2015
Q4 		$1.2M Buy
+10,055
New +$1.16M 0.09% 46
2015
Q1 		– Sell
-342,349
Closed -$38.3M – 72
2014
Q4 		$38.3M Sell
342,349
-27,051
-7% -$2.85M 4.17% 8
2014
Q3 		$35M Buy
+369,400
New +$33.3M 4.04% 5
2014
Q1 		– Sell
-366,036
Closed -$30.9M – 74
2013
Q4 		$30.9M Buy
366,036
+168,836
+86% +$13.4M 3.82% 4
2013
Q3 		$15.2M Sell
197,200
-204,600
-51% -$14.3M 2.29% 17
2013
Q2 		$23.5M Buy
+401,800
New +$24.2M 4.14% 7

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Redmile Group's CELG Position: Q4 2019 in Review

Redmile Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 562,700 shares — an estimated $55.9M sold.

Redmile Group first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $68.1M in Q4 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Redmile Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Redmile Group sold 562,700 Celgene Corp shares in Q4 2019, an estimated $55.9M.
  • Redmile Group first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
  • Redmile Group's Celgene Corp position peaked at $68.1M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Redmile Group's 13F filing for Q4 2019, filed 14 Feb 2020.